Reshma Jagsi interviewed for mCancer Talk

Reshma Jagsi was interviewed by mCancerTalk for the article, “Is your course of radiation treatment longer than it needs to be?” which focuses on two of her radiation treatment studies. In one of her studies, looking at a national database of patients, she and her colleagues found that hypofractionated radiation therapy was used in only 13.6% of Medicare patients with breast cancer. In Michigan, Jagsi’s other study found, fewer than one-third of patients who fit the criteria for offering this approach got the shorter course of treatment.

Read Dr. Jagsi’s paper about hypofractionation use nationally and in Michigan.